Microfluidics

What Microfluidics does

Microfluidics Corporation, founded in 1983 and headquartered in Newton, Massachusetts, is a specialty manufacturer of Microfluidizer high-pressure homogenizers used for cell disruption, nanoparticle fabrication, and uniform particle size reduction. The company operates as a subsidiary within IDEX MPT Group, the particle processing platform of IDEX Corporation (NYSE: IEX). Its core technology is built around fixed-geometry microchannel interaction chambers that generate ultra-high shear forces, enabling consistent processing from 1 mL benchtop volumes to thousands of liters per hour at production scale. The product portfolio is organized into three tiers: lab/benchtop processors (LM10, LM20, M110P, LV1, M110Y, HC Series, TAMARA), pilot-scale units (M110EH, M815), and production-scale systems (M700 Series, MP350 Microlyser), supplemented by proprietary replacement interaction chambers and maintenance services.

The company sells through a direct enterprise field sales model targeting pharmaceutical, biopharmaceutical, and biotechnology manufacturers, with primary applications in lipid nanoparticles for mRNA therapeutics, vaccine adjuvants, liposomes, cell disruption for protein extraction, nanoemulsions, and drug delivery systems. Secondary verticals include cosmetics, nutraceuticals/food, cannabis, chemical/industrial, and energy. Revenue is generated through one-time capital equipment sales, recurring aftermarket services and spares, and pre-sale lab testing services. Quote-based pricing applies across all tiers with no public pricing disclosed. The company maintains a global distribution footprint with regional presence in Germany and China, supported by the broader IDEX MPT service network. Named customers include Abcam Plc, MIT, Vrije Universiteit Amsterdam, Forschungszentrum Rossendorf, and UMass Amherst, with multiple documented multi-year enterprise relationships.

Microfluidics competes in the high-pressure homogenization segment against alternative technologies including French pressure cells, ultrasonication, and bead mills, differentiating on shear performance, batch-to-batch uniformity, and validated scale-up. The installed base, proprietary interaction chamber consumables, and GMP qualification switching costs create a recurring revenue profile. The company is part of the IDEX MPT Group alongside complementary brands Fitzpatrick, Matcon, Quadro, and Quadro Liquids, all focused on precision particle processing and powder/fluid handling technologies.

Name

Microfluidics

Legal name

Microfluidics Corporation

Website

https://microfluidicscorp.com

Company type

Private

Founded year

1983

Operating status

Operating

Headcount range

51–100 employees

Short description

Microfluidics Corporation manufactures Microfluidizer high-pressure homogenizers for cell disruption and nanoparticle processing, serving pharmaceutical, biopharmaceutical, and biotechnology manufacturers globally as part of IDEX MPT Group.

Ownership category

akta.pro rank

Product category

Pharmaceutical Processing Equipment

NAICS

Measuring, Dispensing, and Other Pumping Equipment Manufacturing (333914)

SIC

Pumps & Pumping Equipment (3561)

akta.pro primary industry

Crystallization, Particle Engineering & Micronization Services (HLAGAHAJ)

akta.pro secondary industry

Microbiome Manufacturing, Formulation & Delivery Technologies (encapsulation, spores, oral delivery) (HLAAAFAJ)

Keywords

• High pressure homogenizers
• Nanoparticle processing equipment
• Cell disruption processors
• Fluid processing equipment
• Pharmaceutical manufacturing equipment

Headquarters

HQ city

Newton

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Capital Equipment Sales: Sale of Microfluidizer processors across lab, pilot, and production scales. One-time capital expenditure for high-value industrial equipment with long useful lifespans.
2. Aftermarket Services & Spares: Replacement interaction chambers, maintenance services, and support packages. Recurring revenue from consumables and service contracts supporting installed base.
3. Lab Testing Services: Equipment and lab testing services for prospective customers to evaluate technology capabilities before purchase decision.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

Microfluidics Corporation manufactures and sells Microfluidizer® high-pressure homogenizer processors that use fixed-geometry microchannel interaction chambers to deliver ultra-high shear forces for nanoparticle fabrication, cell disruption, and uniform particle size reduction. The portfolio spans lab/benchtop, pilot, and production-scale systems, supported by aftermarket interaction chambers, maintenance services, and lab testing capabilities for pharmaceutical, biopharmaceutical, vaccine, cosmetic, nutraceutical, chemical, and cannabis customers worldwide.

Product overview

Microfluidics Corporation (operating as IDEX MPT) offers a comprehensive portfolio of Microfluidizer® high-pressure homogenizers designed for nanotechnology applications including uniform nanoemulsions, cell disruption, and particle size reduction. The product line spans three scale tiers: Lab Scale/Benchtop processors (LM10, LM20, M110P, LV1, M110Y, HC Series, TAMARA) for research and development; Pilot Scale processors (M110EH, M815) for scale-up validation; and Production Scale processors (M700 Series, MP350 Microlyser) for commercial manufacturing. All processors utilize the proprietary Microfluidizer® technology to achieve high shear fluid processing with uniform treatment regardless of batch size. The portfolio also includes aftermarket components (interaction chambers) and maintenance services. Applications span biotechnology, pharmaceuticals, vaccines, energy, chemicals, cosmetics, nutraceuticals, and cannabis industries, with specific uses including nanoemulsions, lipid nanoparticles, liposomes, vaccine adjuvants, drug carriers, cell disruption, polymer nanoparticles, and nanoencapsulation.

Differentiator

Problem solved

Functional benefit

Brands

• Microfluidizer®: Proprietary high shear fluid processor technology for nanoparticle size reduction, cell disruption, and uniform particle size distributions.
• Microlyser™

Products and services

• LM10 Microfluidizer Lab-scale benchtop high-pressure homogenizer designed for nanoparticle processing and uniform particle size reduction in research and development applications.
• LM20 Microfluidizer Lab-scale benchtop high-pressure homogenizer offering superior cell disruption with digital pressure controls and scalable processing from milliliters to hundreds of milliliters.
• M110P Microfluidizer Lab-scale high-pressure microfluidizer processor for nanoparticle applications.
• LV1 Low Volume Microfluidizer Low-volume lab-scale microfluidizer designed for processing small batch sizes.
• M110Y Microfluidizer Lab-scale high-pressure microfluidizer processor for laboratory applications.
• HC Series Microfluidizers (HC5000/HC8000) High-capacity microfluidizer processors designed for larger-scale processing requirements.
• TAMARA Microfluidizer Specialized microfluidizer processor for specific application requirements.
• M110EH Microfluidizer Pilot-scale high-pressure microfluidizer for scaling up from laboratory to production processes.
• M815 Microfluidizer Pilot-scale high-pressure processor for mid-range production volume processing.
• M700 Series Microfluidizers Production-scale high-pressure microfluidizer processors designed for large-volume commercial manufacturing.
• MP350 Microlyser™ Processor Production-scale microfluidizer-based processor for continuous large-volume processing.
• Microfluidizer Interaction Chambers Precision-manufactured replacement interaction chambers for Microfluidizer processors, sold as aftermarket components.
• Equipment Maintenance Services Comprehensive maintenance, technical support, and service packages for installed Microfluidizer equipment.

Quantifiable outcome

• 99% bacterial cell disruption in 2-3 passes vs 5-10 passes required by alternative methods
• +2 more outcomes

Named customers5 records

Segments6 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• GEA Group: GEA is a major manufacturer of high-pressure homogenizers (including Niro Soavi and PandaPLUS lines) used for particle size reduction, cell disruption, and nanoemulsion manufacturing across pharmaceutical, biotech, dairy, and food applications, directly comparable to Microfluidizer equipment.
• SPX FLOW: SPX FLOW (including the legacy APV homogenizer portfolio) manufactures high-pressure homogenizers and fluid processing equipment for pharmaceutical, biotech, food, and chemical applications, directly competing with Microfluidics in pharmaceutical manufacturing equipment.
• Constant Systems: Constant Systems specializes in high-pressure cell disruption equipment for biotechnology, microbiology, and protein extraction applications, directly competing with Microfluidizer processors in the cell disruption use case.
• Hielscher Ultrasonics: Hielscher manufactures industrial ultrasonic processors for cell disruption, nanoparticle synthesis, and homogenization. As an alternative-technology competitor, it competes with Microfluidics for the same biotech and pharmaceutical customers seeking particle size reduction solutions.
• Sonic Corporation: Sonic Corporation manufactures ultrasonic liquid processors for cell disruption, homogenization, and nanoparticle applications. Competes directly with Microfluidics in laboratory and production cell disruption use cases via alternative ultrasonic technology.
• ATS Scientific: ATS Scientific distributes and manufactures homogenization and cell disruption equipment for laboratory and pharmaceutical research, competing with Microfluidizer processors in life science research applications.

Broad incumbents

• Bühler Group: Bühler is a large diversified industrial process equipment manufacturer serving food, pharma, and chemical markets with grinding, homogenization, and particle processing equipment. Overlaps with Microfluidics in particle size reduction and dispersion, but operates as a much broader portfolio incumbent.
• Netzsch Group: Netzsch manufactures grinding, dispersing, and homogenization equipment for pharmaceutical, chemical, and food applications. Its high-pressure homogenizer and bead mill products overlap with Microfluidizer use cases in particle size reduction.

Others

• Fitzpatrick (IDEX MPT): Fitzpatrick is a sister company under IDEX MPT Group specializing in dry granulation, hammer milling, and particle processing. As an IDEX MPT portfolio peer, Fitzpatrick shares distribution and customer relationships with Microfluidics for integrated particle processing solutions.

Emerging players

• Microinnova Engineering: Microinnova manufactures continuous flow reactors and microfluidic processing equipment for pharmaceutical and chemical applications, representing an emerging alternative-technology peer that overlaps with Microfluidics in continuous flow nanoparticle and API manufacturing.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCXWgOO1jWKIykC2vDCx5EVA
• LinkedInlinkedin.com/company/microfluidics

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Microfluidics